Search Results 231-240 of 16513 for Zonisamide

  1. Temazepam (oral route) - Side effects & dosage - Mayo Clinic

    An alternative to this medication should be prescribed or you should stop breastfeeding while using this medicine. Drug Interactions. Although certain medicines ...

  2. Celecoxib (oral route) - Side effects & dosage - Mayo Clinic

    Celecoxib is a nonsteroidal anti-inflammatory drug (NSAID) used to treat mild to moderate pain and help relieve symptoms of arthritis (eg, osteoarthritis, ...

  3. Bisoprolol and hydrochlorothiazide (oral route) - Side effects & dosage - Mayo Clinic

    High blood pressure adds to the workload of the heart and arteries. If it continues for a long time, the heart and arteries may not function properly. This can ...

  4. Ibandronate (intravenous route) - Side effects & uses - Mayo Clinic

    Ibandronate injection is used to treat osteoporosis (thinning of the bone) in women after menopause. This medicine is to be given only by or under the direct ...

  5. Inotuzumab Ozogamicin In Treating Younger Patients With Relapsed Or Refractory CD22 Positive B Acute Lymphoblastic Leukemia - Mayo Clinic

    Immunotoxins, such as inotuzumab ozogamicin, are antibodies linked to a toxic substance and may help find cancer cells that express CD22 and kill them without ...

  6. A Study of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  7. Mirikizumab-mrkz (intravenous route, subcutaneous route) - Side effects & dosage - Mayo Clinic

    Mirikizumab-mrkz injection is used to treat moderate to severe active Crohn's disease and ulcerative colitis. This medicine is available only with your doctor's ...

  8. Phase 2 Study to Evaluate the Oral Combination of Ixazomib (MLN9708) With Cyclophosphamide and Dexamethasone in Patients With Newly Diagnosed or Relapsed and/or Refractory Multiple Myeloma - Mayo Clinic

    About this study. This is a phase 2, multicenter, open-label study in patients with Newly Diagnosed Multiple Myeloma (NDMM) who have not received prior ...

  9. Capivasertib (oral route) - Side effects & dosage - Mayo Clinic

    Capivasertib is used in combination with fulvestrant to treat HR-positive, HER-2 negative breast cancer that is advanced or metastatic (cancer that has spread) ...

  10. Cinacalcet (oral route) - Side effects & dosage - Mayo Clinic

    Cinacalcet is used to treat hyperparathyroidism in patients with chronic kidney disease who are on dialysis. Hyperparathyroidism is a condition that is caused ...